Search Results

Kathryn E Livingston is currently a Product Manager at Gator Bio , a biotechnology company providing Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Since 2019, Nick has combined his university role with the leadership of Excellerate Bioscience as Chief Nicholas Holliday on the web LinkedIn ORCID University of Nottingham Twitter Excellerate Bio Dr. Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Not OK to use: Advertising Spam Anything misleading or annoying Social media bios Paying or offering

You’ll be asked for: Instructor info – name, email, affiliation, short bio, photo, and optional social

. < Back The Spatiotemporal Revolution in GPCR Biology May 21, 2026 10:00 AM - 11:30 AM EST 🔒 Watch This session examines how receptor nanodomains, endosomal signaling compartments, and biomolecular condensates Designed for structural pharmacologists, cell biologists, and drug discovery scientists working on GPCR

Joseph Kim exploring GPCR structural biology, cryo-electron microscopy, opioid receptor pharmacology, Joseph Kim: Structural Biology and Drug Discovery at GPCRs Scientific Abstract G protein-coupled receptors Joseph Kim discusses the intersection of structural biology, membrane protein biochemistry, and drug Joseph Kim is a structural biologist studying membrane proteins and GPCR pharmacology. His work combines structural biology, membrane protein biochemistry, and pharmacological insights to

<< Back to podcast list Strategic Partner(s) Translating computational approaches to GPCR biologists Riccardo Capelli is an assistant professor in Applied Physics at the Department of Biosciences, University methods such as structure-based models and enhanced sampling techniques, as well as their application to biomolecular ResearchGate Bysky App : @ riccardocapelli.bsky.social Twitter X : @ ric_capelli Computational Structural Biology Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

to podcast list Strategic Partner(s) Custom Molecules, Fluorescent Probes: When Chemists Think Like Biologists CSO of Celtarys Research, shares the story behind the company’s journey from academic curiosity to biotech When the time came to decide whether to leave the lab and lead Celtarys into biotech, she took the leap That changed with support from Galicia’s robust biotech network, and the company quickly defined its It’s about enabling biology.” — Maria Majellaro Through its partnership with Dr.

GPCR — Scaling Biotech Beyond the Bench Turning scientific excellence into scalable organizations. Leadership 👉 Ambition is the default setting of biotech. This is the hidden cost of ambition in biotech leadership. Not failure. Not poo Attila Foris Mar 2 The Real Cost of Strategic Overload in Biotech 👉 In early-stage biotech, At the same time, the team is preparing for biotech fundraising.

Transform your biotech idea or data into a clear, strategic roadmap with aligned biology, timelines, Home About Services News Get in Touch Welcome Biotech Growth Wherever You Are in Discovery—Let’s Build a Plan That Moves You Forward Align your biology, timeline and CRO roadmap. Biotech teams often tell me: “We have too many CROs and not enough clarity.” We'll define what matters, when to decide, and how to act—based on your biology, not just what's easy

journeys, groundbreaking discoveries, and the impact of their research on our shared understanding of GPCR biology , exchange, and collaborate in order to improve human health through a deeper understanding of GPCR biology trajectory, discoveries, and how their research contributed to the shared pool of knowledge about GPCR biology

Bengtsson’s research spans sympathetic nervous system signaling, brown adipose tissue biology, and skeletal He is also an entrepreneur and founder of biotechnology companies translating GPCR pharmacology into Early research on brown adipose tissue and thermogenesis 22:30 Translating academic discoveries into biotech Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Sudarshan Rajagopal | Duke University The Spatiotemporal Revolution in GPCR Biology Biased Signaling The classes are designed for researchers, students, and professionals in biology, pharmacology, and biochemistry

upcoming GPCR Masterclass live sessions featuring expert discussions on GPCR pharmacology, receptor biology Sudarshan Rajagopal | Duke University The Spatiotemporal Revolution in GPCR Biology Biased Signaling GPCR Masterclass is a live scientific discussion with a leading expert in GPCR pharmacology, receptor biology designed for GPCR researchers, pharmacologists, and drug discovery scientists working in academia, biotech

not just sequence matches — is non-trivial, and it matters for anyone hoping to translate kidney OR biology She received her undergraduate degree in biology from Truman State University and earned her Ph.D. in laboratory of Michael Caplan at Yale University, where she studied both renal physiology and sensory biology Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Her work spans GPCR structural biology, membrane protein stabilization, allosteric modulation, and the Marshall in the room — a new category of GPCR biology opened, with heterodimers as obligate signaling Years of assumed peptide biology dissolved into a simpler truth hidden in the solvent. Oncology Ignored GPCRs for Decades — and Is Paying Attention Now Twenty years ago, cancer biologists Richard Henderson at the Laboratory of Molecular Biology in Cambridge, UK.

chemists, systems biologists, structural biologists, and drug-discovery veterans — drew on their combined Yaroslav Nikolaev is a scientist at InterAx Biotech with a dual background in biology and computation His research combines biomolecular NMR, structural biology, and machine learning to study how GPCRs function True negatives quietly wreck biological models. The explosion of biomedical data such as in genomics, structural biology, and pharmacology can provide

Tom Sakmar's lab, CRISPR knockout generation at NIAID, and class B peptide receptor work at Generate Biomedicines She holds a PhD in Biochemistry from the Université de Montréal, where she trained in Dr. research fellowship in B-cell molecular immunology at NIAID, and a senior scientist role at Generate Biomedicines outside clinical attention Career architecture for bench pharmacologists moving beyond academia and biotech GPCR was founded in March 2020 after a COVID-era redundancy at Generate Biomedicines.

As co-founder and CEO of Keltic Pharma Therapeutics, he leads a biotechnology company developing a novel

Aaron Sato is the Chief Scientific Officer and VP of Protein Engineering at Twist Biopharma, the biologics division of Twist Bioscience. 04:21 Twist Bioscience, Twist Biopharma, and the silicon DNA platform 08:12 Using DNA for long-term Aaron Sato from Twist Biopharma , a vertical within Twist Bioscience . Aaron Sato on the web LinkedIn Twitter Google Scholar Twist Bioscience Twist Biopharma Dr.

Pradhan returns to often: that organisms in chronic pain are fundamentally different biological systems Professor of Psychiatry at the University of Illinois at Chicago, where her lab studies opioid receptor biology the same family produce opposite clinical outcomes Chronic disease states as fundamentally altered biological Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Di Pizio — who leads the computational pharmacology group at the Leibniz Institute for Food Systems Biology independent research group leader in computational pharmacology at the Leibniz Institute for Food Systems Biology computational medicinal chemistry before spending a formative period in Gerhard Klebe's structural biology Antonella Di Pizio, an independent research group leader at the Leibniz Institute for Food Systems Biology Antonella Di Pizio on the web Leibniz-Institute for Food Systems Biology at the Technical University

His lab combines classical pharmacology with cancer genomics, bioinformatics, and synthetic lethality uveal melanoma, GαS mutations across pancreatic, colon, and appendix cancers, and chemokine receptor biology and the druggable FAK node CXCR3 and the chemokine axis that gates immunotherapy response Structural biology produced transforming efficiencies comparable to Ras, and the community largely looked away because the biology from Europe, high-throughput screens from Japan, and biology from UCSD.

trafficking and recycling, and more recently the cannabinoid entourage hypothesis — combining BRET-based biosensors receptor tone Quantitative pharmacology as rescue operation — using operational models and BRET-based biosensors mechanistic story that guided a decade of biased-ligand drug discovery needs rebuilding from the underlying biology Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

signaling — with particularly deep work on beta-adrenergic receptors, cyclic AMP regulation, and receptor biology Biology runs on opposing forces, and good pharmacology learns to see them. 07:40 Expanding the hypothesis — PAR1, PAR4, and upstream pathobiology 11:00 Gas pedals and brakes — biology's Paul Insel "Almost most biological systems are all about gas pedals and brakes. Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

underappreciated axis of pharmacological modulation, and long-running collaborations on beta-adrenergic receptor biology Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Bioinformatics projects flourished. His research spans GPCR signaling in cancer biology, head and neck squamous cell carcinoma, and the molecular The bioinformatics arm called it "heaven." Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Lee is a bioengineer whose first year of graduate school was defined by scheduling thirty-minute appointments He trained as a bioengineer and worked as a research scientist in stem cell and cancer labs before founding episode introduction 01:34 Meeting the co-founders — CEO Lee and CTO Cho 03:11 From stem cell research to bioengineering Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

His lab combines cell and molecular biology with animal pharmacology to identify new signaling regulators Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology